APP and Alzheimer disease: In addition, astrocyte-derived EV has higher expression levels of proteins known to be associated with AD pathogenesis, such as amyloid beta precursor protein (APP), γ-secretase, and β-secretase, than neuron-derived EV, so it is likely to be more useful for diagnosing AD patients [20].